Journal profile · Biochemistry, Genetics and Molecular Biology-Cancer Research
Cellular Oncology
ISSN 1570-5870 · eISSN 2210-7185 · Springer Netherlands · NETHERLANDS · Bimonthly · Founded 2011
Cellular Oncology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.59; fully open access; APC about USD 2,380; median 267 days to acceptance (54 articles, last 24 months); community-reported acceptance: easy; 105 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cellular Oncology is published by Springer Netherlands and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism and Ferroptosis and cancer prognosis, together about 25.9% of its articles. Its main subfields are Oncology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Analytical Cellular Pathology is a peer-reviewed, Open Access journal that provides a forum for scientists, medical practitioners and pathologists working in the area of cellular pathology. The journal publishes original research articles and review articles related to cytology, carcinogenesis, cell receptors, biomarkers, diagnostic pathology, immunopathology, and hematology.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Cancer Research
Editor-in-chief Dimitrios KaramichosPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named United States 6, Italy 5, India 4, Taiwan, China 3, Türkiye 2 (30 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Cells and MetastasisMedicine10.9%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology7.5%
- Ferroptosis and cancer prognosisMedicine7.5%
- Cancer Immunotherapy and BiomarkersMedicine7.2%
- Immune cells in cancerImmunology and Microbiology6.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Pathology | Zone 2 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Pathology | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.59LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 8.6LetPub ·
- CiteScore (publisher)
- 5.8Publisher website ·
- CiteScore (publisher) 2025
- 5.8Publisher website ·
- SJR 2026-06
- 1.56LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 782OpenAlex ·
- 2-year mean citedness
- 4.31OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 51.69%LetPub ·
Volume
- Articles per year
- 98LetPub ·
- Articles per year (publisher) 2025
- 29Publisher website ·
- Downloads per year (publisher) 2025
- 142,907Publisher website ·
Articles by year OpenAlex count · 1,329 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 161 | 161 | 119 |
| 2025 | 105 | 105 | 456 |
| 2024 | 124 | 124 | 1,105 |
| 2023 | 147 | 147 | 2,501 |
| 2022 | 111 | 111 | 2,264 |
| 2021 | 76 | 76 | 2,671 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
267 daysMedian, submission to acceptance · P25–P75 178 days – 401 days
- Acceptance to online
- median 31 days (54 articles)
- Submission to online
- median 303 days
- Sample
- 54 articles with submission and acceptance dates (68 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 22%Publisher website ·
- Acceptance rate (publisher) 2025
- 22%Publisher website ·
- Submission to first decision
- 57 daysPublisher website ·
- Submission to first decision 2025
- 57 daysPublisher website ·
- Submission to acceptance 2025
- 288 daysPublisher website ·
- Acceptance to publication 2025
- 36 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,380 / GBP 1,590 / EUR 1,880 | Yes | CC BY | |
| OpenAlex | USD 4,390 / EUR 3,390 / GBP 2,790 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- Chicago
- First submission
- Free format: the journal's layout is not required
Article types accepted7
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articlesResearch articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide…Length not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- reviewsA review article provides an overview of the published literature in a particular subject area.Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Max 3 concurrent submissions Model summary
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- License & copyright Copyright and permissions
Copyright retained; CC BY license Model summary
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Open access
Open access journal Model summary
Analytical Cellular Pathology is an open access journal
Source ↗Publisher website ·- Peer review Peer review
Single-anonymized peer review model Model summary
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Preprints Preprints
Preprint servers accepted Model summary
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2011
- ISSN
- 1570-5870
- Print ISSN
- 2210-7177
- Electronic ISSN
- 2210-7185
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cellular Oncology
What CAS zone is Cellular Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cellular Oncology is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology / Pathology / Cell Biology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cellular Oncology?
The latest impact factor listed by LetPub is 5.59; CiteScore 8.6, h-index 76.
How long does peer review take at Cellular Oncology?
Based on the dates recorded on 54 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 267 days (interquartile range 178–401 days); authors report an average review time of about 16 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 22% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cellular Oncology?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cellular Oncology based?
Of the 30 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (6), Italy (5) and India (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Cellular Oncology?
According to LetPub and DOAJ records, Cellular Oncology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Cellular Oncology open access, and what is the APC?
Cellular Oncology is a fully open-access journal. APC about USD 2,380.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .